Corvex funds linked to Keith Meister buy 1.2M GeneDx (WGS) shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GeneDx Holdings Corp. reported significant insider buying linked to director and ten percent owner Keith A. Meister. Investment funds advised by Corvex Management LP made open-market purchases totaling 1,205,147 shares of Class A Common Stock between May 7 and May 11, 2026, at weighted average prices generally in the mid-$30s to low-$40s per share. After these trades, the Corvex-advised funds directly held 4,433,297 shares of Class A Common Stock. The filing states Mr. Meister may be deemed to indirectly beneficially own these shares through his control of Corvex’s general partner, while both Corvex and Mr. Meister disclaim beneficial ownership beyond their pecuniary interest. The filing also notes 333,144 shares held of record by CMLS Holdings LLC, where Mr. Meister shares voting and investment discretion, and 20,129 shares issued to Mr. Meister upon vesting of restricted stock units for his board service.
Positive
- None.
Negative
- None.
Insights
Corvex-linked entities reported sizeable open-market share purchases in GeneDx.
Investment funds advised by Corvex Management LP, associated with director and ten percent owner Keith A. Meister, bought 1,205,147 GeneDx Class A shares in open-market transactions between May 7 and May 11, 2026. These trades were executed across price ranges generally spanning $34.97 to $41.50 per share, using weighted average prices in the Form 4.
Following these purchases, Corvex-advised funds directly held 4,433,297 Class A shares. Additional positions include 333,144 shares held by CMLS Holdings LLC, where Mr. Meister shares voting and investment discretion, and 20,129 shares issued to him upon vesting of restricted stock units for board service. Corvex and Mr. Meister formally disclaim beneficial ownership beyond their pecuniary interest.
The filing reflects pure cash, non-derivative buying, with no option exercises or sales reported in this period. Actual implications for the company’s ownership structure depend on the overall share base and any future transactions disclosed in subsequent filings.
Insider Trade Summary
Net Buyer: 1,205,147 shares ($46,806,729)
Net Buy
15 txns
Insider
Meister Keith A., Corvex Management LP
Role
null | null
Bought
1,205,147 shs ($46.81M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Class A Common Stock | 246,734 | $38.91 | $9.60M |
| Purchase | Class A Common Stock | 252,734 | $39.65 | $10.02M |
| Purchase | Class A Common Stock | 532 | $40.35 | $21K |
| Purchase | Class A Common Stock | 15,745 | $38.00 | $598K |
| Purchase | Class A Common Stock | 3,396 | $38.70 | $131K |
| Purchase | Class A Common Stock | 79,144 | $40.67 | $3.22M |
| Purchase | Class A Common Stock | 73,104 | $41.15 | $3.01M |
| Purchase | Class A Common Stock | 128,181 | $35.46 | $4.55M |
| Purchase | Class A Common Stock | 14,786 | $36.33 | $537K |
| Purchase | Class A Common Stock | 123,393 | $37.60 | $4.64M |
| Purchase | Class A Common Stock | 116,412 | $38.46 | $4.48M |
| Purchase | Class A Common Stock | 94,356 | $39.39 | $3.72M |
| Purchase | Class A Common Stock | 56,630 | $40.46 | $2.29M |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 4,180,031 shares (Indirect, See footnotes);
Class A Common Stock — 20,129 shares (Direct, null)
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $34.97 to $35.94. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15) to this Form 4. Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $35.97 to $36.84. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.05 to $38.04. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.05 to $39.04. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.05 to $40.04. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.05 to $40.66. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.59 to $38.58. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.59 to $38.94. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.95 to $40.94. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.95 to $41.50. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.22 to $39.21. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.22 to $40.21. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.22 to $40.41. CMLS Holdings LLC ("CMLS Holdings") is the record holder of 333,144 shares of the Class A Common Stock reported herein. Mr. Meister is one of two members of the Board of Managers of CMLS Holdings, and Mr. Meister shares voting and investment discretion with respect to the securities held of record by CMLS Holdings reported herein. The shares of Class A Common Stock reflected as beneficially owned by Mr. Meister include 20,129 shares of Class A Common Stock that were issued upon the vesting of restricted stock units, that were granted to Mr. Meister in connection with his service on the board of directors of the Issuer.
Key Figures
Net shares bought: 1,205,147 shares
Corvex-advised funds holdings: 4,433,297 shares
CMLS Holdings position: 333,144 shares
+3 more
6 metrics
Net shares bought
1,205,147 shares
Total open-market purchases between May 7–11, 2026
Corvex-advised funds holdings
4,433,297 shares
Class A Common Stock directly held after reported trades
CMLS Holdings position
333,144 shares
Class A Common Stock held of record by CMLS Holdings LLC
RSU-based direct holding
20,129 shares
Class A Common Stock issued to Keith A. Meister upon RSU vesting
Lowest price range
$34.97–$35.94
Weighted-average purchase range noted in footnote F1
Highest price range
$40.95–$41.50
Weighted-average purchase range noted in footnote F12
Key Terms
weighted average price, beneficial ownership, pecuniary interest, restricted stock units, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his or its pecuniary interest therein."
restricted stock units financial
"shares of Class A Common Stock that were issued upon the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Section 16 of the Securities Exchange Act of 1934 regulatory
"for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
FAQ
Over what dates did the GeneDx (WGS) insider purchases in this Form 4 occur?
The reported insider purchases occurred between May 7 and May 11, 2026. During this period, Corvex-advised funds executed multiple open-market transactions in GeneDx Class A Common Stock at weighted average prices in the mid-$30s to low-$40s per share.